Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 18605638 | NEUROMODULATION WAVEFORM WATERMARKING AND PRESCRIBING | March 2024 | September 2024 | Allow | 6 | 2 | 0 | Yes | No |
| 18587367 | SYSTEM AND METHOD FOR IDENTIFYING TRANSDIAGNOSTIC FEATURES SHARED ACROSS MENTAL HEALTH DISORDERS | February 2024 | January 2026 | Abandon | 22 | 1 | 0 | No | No |
| 18411959 | TRACKER MODULE FOR MONITORING THE USE OF A RESPIRATORY DEVICE | January 2024 | July 2025 | Allow | 18 | 1 | 0 | No | No |
| 18528512 | SYSTEM AND METHOD FOR MOBILE MEDICATION TRACKING | December 2023 | December 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18514181 | METHODS AND SYSTEMS FOR SELECTING A MACHINE LEARNING ALGORITHM | November 2023 | March 2025 | Allow | 16 | 1 | 0 | No | No |
| 18500624 | ELECTROCARDIOGRAM-BASED GLOBAL DIAGNOSTIC SYSTEMS AND METHODS | November 2023 | October 2025 | Abandon | 23 | 1 | 0 | No | No |
| 18493544 | COMPUTER SYSTEM FOR CRISIS STATE DETECTION AND INTERVENTION | October 2023 | April 2025 | Allow | 18 | 1 | 0 | No | No |
| 18461454 | COMPUTER-READABLE RECORDING MEDIUM STORING INFORMATION PROCESSING PROGRAM, METHOD FOR PROCESSING INFORMATION, AND INFORMATION PROCESSING APPARATUS | September 2023 | September 2025 | Abandon | 25 | 1 | 0 | No | No |
| 18227425 | SYSTEM AND METHOD FOR AN ENHANCED HEALTHCARE PROFESSIONAL USER INTERFACE DISPLAYING MEASUREMENT INFORMATION FOR A PLURALITY OF USERS | July 2023 | September 2024 | Allow | 14 | 2 | 0 | Yes | No |
| 18220936 | SYSTEMS AND METHODS FOR IMPROVING INTERACTIONS OF INSURANCE PROVIDERS, PRESCRIBING HEALTHCARE PROFESSIONALS, AND MEMBERS ASSOCIATED WITH A HIGH VOLUME PHARMACY | July 2023 | January 2026 | Abandon | 30 | 2 | 0 | No | No |
| 18336938 | ELECTRONIC SYSTEMS AND METHODS FOR THE ASSESSMENT OF EMOTIONAL STATE | June 2023 | February 2025 | Allow | 20 | 1 | 0 | No | No |
| 18184377 | SYSTEM AND METHOD FOR DETECTING, FORESTALLING AND TREATING CANCER PATIENTS USING ARTIFICIAL INTELLIGENCE | March 2023 | May 2025 | Abandon | 27 | 1 | 0 | No | No |
| 18024095 | SYSTEM AND METHOD FOR DIAGNOSING AND STAGING NEURODEGENERATIVE DISEASES ON THE BASIS OF THE SURFACE ROUGHNESS OF RETINAL LAYERS | March 2023 | January 2026 | Abandon | 35 | 2 | 0 | Yes | No |
| 18165756 | SYSTEM FOR REMOTE TREATMENT UTILIZING PRIVACY CONTROLS | February 2023 | May 2025 | Allow | 28 | 1 | 0 | Yes | No |
| 18068223 | PREDICTING CHRONIC KIDNEY DISEASE PROGRESSION | December 2022 | February 2025 | Allow | 26 | 1 | 0 | Yes | No |
| 17992652 | MULTI-PLATFORM PRESCRIPTION ROUTING SYSTEM | November 2022 | February 2025 | Allow | 27 | 4 | 0 | Yes | No |
| 17942393 | SYSTEM AND METHOD FOR PREDICTIVE RISK ASSESSMENT AND INTERVENTION | September 2022 | April 2025 | Abandon | 31 | 4 | 0 | Yes | No |
| 17817174 | SYSTEM AND METHOD FOR DECREASING TURNAROUND FOR PRE-AUTHORIZATIONS USING A SMART REQUEST FOR INFORMATION MODEL | August 2022 | August 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17859608 | VIRTUAL MEDICAL ASSISTANT METHODS AND APPARATUS | July 2022 | January 2025 | Allow | 30 | 1 | 0 | Yes | No |
| 17757984 | PREDICTING AND ADDRESSING SEVERE DISEASE IN INDIVIDUALS WITH SEPSIS | June 2022 | January 2026 | Abandon | 43 | 3 | 0 | Yes | No |
| 17656963 | DECISION SUPPORT SYSTEM USING AN ARTIFICIAL INTELLIGENCE (AI) FRAMEWORK FOR SUGGESTING CODES FOR A CLINICAL RECORD FOR A PATIENT AND RELATED METHODS AND COMPUTER PROGRAM PRODUCTS | March 2022 | April 2025 | Allow | 36 | 2 | 0 | Yes | No |
| 17695635 | MEDICAL INFORMATION PROCESSING APPARATUS, AND MEDICAL INFORMATION LEARNING APPARATUS | March 2022 | July 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17693594 | SAFEGUARDS AGAINST USAGE OF INCORRECT PORTABLE MEDICINE DELIVERY DEVICES | March 2022 | August 2025 | Allow | 41 | 3 | 0 | Yes | No |
| 17310552 | SCHEDULE CALCULATION DEVICE, SCHEDULE MANAGEMENT SYSTEM, AND SCHEDULE CALCULATION METHOD | February 2022 | March 2025 | Abandon | 43 | 2 | 0 | No | No |
| 17581648 | SYSTEM, METHOD, AND COMPUTER PROGRAM PRODUCT FOR PREDICTIVE MAINTENANCE | January 2022 | September 2024 | Allow | 32 | 4 | 0 | Yes | No |
| 17553037 | ANESTHESIOLOGICAL PROCEDURE RECORDING SYSTEM AND METHOD | December 2021 | May 2025 | Abandon | 41 | 2 | 0 | No | No |
| 17545114 | Template and Method for Inputting and Disseminating Occupational and Physical Therapy Information | December 2021 | March 2025 | Abandon | 39 | 2 | 0 | Yes | No |
| 17611733 | REMOTE HEALTH MONITORING SYSTEM AND METHOD FOR HOSPITALS AND CITIES | November 2021 | November 2025 | Abandon | 48 | 3 | 0 | No | No |
| 17524532 | METHOD FOR COMPREHENSIVE MANAGEMENT OF A HEALTH CONDITION | November 2021 | October 2024 | Abandon | 35 | 2 | 0 | No | No |
| 17605848 | MEDICAL DEVICE AND METHOD FOR REMOTE-CONTROL OF A MEDICAL DEVICE | October 2021 | April 2025 | Allow | 42 | 4 | 0 | No | No |
| 17451463 | SYSTEM AND METHODS FOR EXAM SUGGESTIONS USING A CLUSTERED DATABASE | October 2021 | November 2024 | Abandon | 37 | 2 | 0 | No | No |
| 17501471 | SYSTEM AND METHOD FOR CONTACTLESS MONITORING AND EARLY PREDICTION OF A PERSON | October 2021 | July 2025 | Allow | 45 | 3 | 0 | Yes | Yes |
| 17497324 | AUTOMATED TRANSFORMATION DOCUMENTATION OF MEDICAL DATA | October 2021 | March 2025 | Allow | 41 | 3 | 0 | Yes | No |
| 17483847 | TWO-PHASED MEDICAL DIAGNOSIS | September 2021 | February 2026 | Abandon | 52 | 4 | 0 | Yes | Yes |
| 17447365 | HEALTHY BEHAVIOR SUPPORT DEVICE, METHOD, AND NON-TRANSITORY STORAGE MEDIUM STORING PROGRAM | September 2021 | August 2025 | Abandon | 47 | 4 | 0 | Yes | No |
| 17402129 | System, Mobile Application and Process for an Advanced Recovery Device | August 2021 | June 2025 | Abandon | 46 | 4 | 0 | No | No |
| 17221736 | Validation of Health Status Information | April 2021 | October 2024 | Abandon | 43 | 3 | 0 | No | Yes |
| 17271473 | SYSTEM AND METHOD FOR REMOTELY OBTAINING DONOR INFORMATION | February 2021 | February 2026 | Abandon | 59 | 4 | 0 | No | No |
| 17178966 | PROCEDURE FOR THE GLOBAL UNIFIED REGISTRATION AND UNIVERSAL IDENTIFICATION OF DONORS | February 2021 | August 2024 | Allow | 42 | 2 | 0 | No | No |
| 17056939 | MEDICAL ADHERENCE SYSTEM AND METHOD | November 2020 | April 2025 | Allow | 53 | 2 | 0 | Yes | No |
| 17052661 | Treatment plan facilitator | November 2020 | October 2024 | Abandon | 47 | 2 | 0 | Yes | No |
| 17075049 | SYSTEM FOR REMOTE TREATMENT UTILIZING PRIVACY CONTROLS | October 2020 | November 2025 | Allow | 60 | 5 | 1 | Yes | No |
| 16980136 | Systems and Methods for Neuro-Behavioral Relationships in Dimensional Geometric Embedding (N-Bridge) | September 2020 | July 2024 | Allow | 46 | 3 | 0 | No | No |
| 16995184 | SYSTEM AND METHOD FOR EFFICIENT EQUIPMENT RESOURCE ALLOCATION | August 2020 | December 2024 | Abandon | 52 | 4 | 0 | No | No |
| 16912456 | CLINICAL ASSESSMENT TOOL | June 2020 | May 2025 | Abandon | 59 | 6 | 0 | Yes | No |
| 16890477 | METHOD OF PREVENTING PHARMACEUTICAL FRAUD USING INTEGRATED IDENTITY MANAGEMENT | June 2020 | November 2024 | Abandon | 53 | 4 | 0 | Yes | No |
| 16879176 | SYSTEM AND METHOD OF INTEGRATED UNIQUE IDENTITY MANAGEMENT | May 2020 | December 2024 | Abandon | 55 | 5 | 0 | Yes | No |
| 16758729 | SYSTEM AND METHOD FOR ASSESSING PHYSIOLOGICAL STATE | April 2020 | February 2025 | Allow | 58 | 5 | 0 | Yes | No |
| 16840227 | Automated Medical Diagnosis, Risk Management, and Decision Support Systems and Methods | April 2020 | December 2024 | Abandon | 56 | 6 | 0 | Yes | No |
| 16583652 | INFORMATION PROVISION METHOD, INFORMATION PROCESSING SYSTEM, INFORMATION TERMINAL, AND INFORMATION PROCESSING METHOD | September 2019 | May 2025 | Abandon | 60 | 4 | 0 | Yes | Yes |
| 16577817 | INFORMATION PROVISION METHOD, INFORMATION PROCESSING SYSTEM, INFORMATION TERMINAL, AND INFORMATION PROCESSING METHOD | September 2019 | June 2025 | Abandon | 60 | 3 | 0 | Yes | Yes |
| 16274874 | SYSTEM AND METHOD FOR PHYSICAL ACTIVITY INFORMED DRUG DOSING | February 2019 | July 2025 | Allow | 60 | 10 | 1 | Yes | No |
| 16324682 | PERSONALIZED NUTRITIONAL RECOMMENDATIONS USING BIOMARKER DATA | February 2019 | October 2025 | Abandon | 60 | 5 | 0 | Yes | Yes |
| 16235093 | SYSTEMS AND METHODS FOR INTEGRATING A GLOBALLY SECURE COMMUNICATIONS NETWORK WITH STORED MEDICAL DIAGNOSTICS | December 2018 | February 2025 | Allow | 60 | 9 | 0 | Yes | Yes |
| 16159471 | HEALTHCARE FULFILLMENT METHODS AND SYSTEMS | October 2018 | August 2024 | Allow | 60 | 7 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner PAULSON, SHEETAL R..
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 12.5% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner PAULSON, SHEETAL R. works in Art Unit 3681 and has examined 31 patent applications in our dataset. With an allowance rate of 35.5%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 52 months.
Examiner PAULSON, SHEETAL R.'s allowance rate of 35.5% places them in the 6% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by PAULSON, SHEETAL R. receive 4.00 office actions before reaching final disposition. This places the examiner in the 97% percentile for office actions issued. This examiner issues more office actions than most examiners, which may indicate thorough examination or difficulty in reaching agreement with applicants.
The median time to disposition (half-life) for applications examined by PAULSON, SHEETAL R. is 52 months. This places the examiner in the 4% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +17.1% benefit to allowance rate for applications examined by PAULSON, SHEETAL R.. This interview benefit is in the 58% percentile among all examiners. Recommendation: Interviews provide an above-average benefit with this examiner and are worth considering.
When applicants file an RCE with this examiner, 12.8% of applications are subsequently allowed. This success rate is in the 8% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 0.0% of cases where such amendments are filed. This entry rate is in the 3% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.
This examiner withdraws rejections or reopens prosecution in 33.3% of appeals filed. This is in the 5% percentile among all examiners. Strategic Insight: This examiner rarely withdraws rejections during the appeal process compared to other examiners. If you file an appeal, be prepared to fully prosecute it to a PTAB decision. Per MPEP § 1207, the examiner will prepare an Examiner's Answer maintaining the rejections.
When applicants file petitions regarding this examiner's actions, 200.0% are granted (fully or in part). This grant rate is in the 100% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 40% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 42% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.